-+ 0.00%
-+ 0.00%
-+ 0.00%

ONCTERNAL THERAPEUTICS ANNOUNCES UPDATED SAFETY AND EFFICACY DATA FOR PHASE 1/2 STUDY OF ONCT-534 FOR THE TREATMENT OF R/R METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

Reuters·10/22/2024 13:00:01

Please log in to view news